MEDINA MARRERO, LAURA BST
lmedina@bst.cat
Bosch Llobet, M. Alba BST
Ene, Gabriela Simona BST
Ferrer Garrido, Gonzalo Jose BST
Sanz Linares, Gabriela BST
(JIF 2024)
-Muñoz NG, Ortega S, Solanich X, Cid J, Díaz M, Moreno AB, Ancochea Á, Santos M, Hernández I, Sanchez JM, Luaña A, García J, Escoda L, Medina L, Ferrer GJ, López J, Céspedes R, Díaz JA, Pons V, Valcárcel D, Grifols JR. Diagnosis and clinical management of thrombotic thrombocytopenic purpura (TTP): a consensus statement from the TTP Catalan group. Blood Transfusion. 2024; 22(2). DOI:10.2450/BloodTransfus.522. PMID:37677097. IF:2,300 (Q2/5D). Document type: Article.
-Romera Martínez I, Avendaño-Solá C, Villegas Da Ros C, Bosch Llobet A, García Erce JA, González Fraile MI, Guerra Domínguez L, Vicuña Andrés I, Anguita Velasco J, González Rodríguez VP, Contreras E, Urcelay Uranga S, Pajares Herraiz ÁL, Jimenez-Marco T, Ojea Pérez AM, Arroyo Rodríguez JL, Pérez-Olmeda M, Ramos-Martínez A, Velasco-Iglesias A, Bueno Cabrera JL, Duarte RF. Factors related to the development of high antibody titres against SARS-CoV-2 in convalescent plasma donors from the ConPlas-19 trial. Vox Sang. 2024; 119(1):27-33. DOI:10.1111/vox.13561. PMID:37986640. IF:1,600 (Q3/7D). Document type: Article.
(JIF 2023)
-Fernandez J, Delgadillo J, Vives J, Rodriguez L, Mendoza A, Azqueta C, Garcia A, Valdivia E, Martorell L, Rubio N, Linares M, Alonso S, Ancochea A, Garcfa E, García N, Medina L, Querol S. A hub-and-spoke model to deliver effective access to chimeric antigen receptor T-cell therapy in a public health network: the Catalan Blood and Tissue Bank experience. CYTOTHERAPY. 2023; 25(1). DOI:10.1016/j.jcyt.2022.07.011. PMID:36041984. IF:3,700 (Q1/3D). Document type: Article.
-Martínez IR, Avendaño C, Da CV, Llobet AB, Erce J, Fraile M, Domínguez LG, Andrés IV, Velasco JA, Rodríguez VPG, Contreras E, Uranga SU, Herraiz A, Jimenez T, Pérez A, Rodríguez J, Pérez M, Ramos A, Velasco A, Cabrera JLB, Duarte RF. Factors related to the development of high antibody titres against SARS-CoV-2 in convalescent plasma donors from the ConPlas-19 trial. VOX SANGUINIS. 2023; 119(1). DOI:10.1111/vox.13561. PMID:37986640. IF:1,800 (Q3/7D). Document type: Article.
-Pascual C, Salmeron PP, Ruiz FT, Ferreiras DV, Hernandez SJ, Argente RS, Galan CD, Comos JD. Immune thrombotic thrombocytopenic purpura: clinical suspicion and basic management in emergency departments – an expert review and consensus statement from the Spanish societies of hematology and hemotherapy (SEHH) and emergency medicine (SEMES). Emergencias. 2023; 35(1). PMID:36756916. IF:5,400 (Q1/1D). Document type: Review.
-Regalado I, Garcia M, Medina L, Fernandez J, Esquirol A, Garcia I, Martino R, Briones J, Sierra J, Novelli S. Age, CD34+cell dose, conditioning and pre-transplant cytopenias can help predict transfusion support in lymphoma patients undergoing autologous stem cell transplantation. VOX SANGUINIS. 2023; 118(8). DOI:10.1111/vox.13486. PMID:37356813. IF:1,800 (Q3/7D). Document type: Article.
(JIF 2022)